TABLE 1.
Clinicopathological features.
| ATX expression | p‐Values | |||
|---|---|---|---|---|
| Variables | Number | Low (n = 14) | High (n = 22) | |
| Sex | ||||
| Male | 18 | 8 | 10 | 0.733 |
| Female | 18 | 6 | 12 | |
| Age, year | ||||
| ≥60 | 18 | 7 | 11 | 1 |
| <60 | 18 | 7 | 11 | |
| Tumor location | ||||
| Head | 11 | 6 | 5 | 0.273 |
| Body/tail | 25 | 8 | 17 | |
| Tumor size, cm | ||||
| ≥2 | 15 | 7 | 8 | 0.701 |
| <2 | 20 | 7 | 13 | |
| TNM stage | ||||
| I–II | 21 | 8 | 13 | 1 |
| III–IV | 15 | 6 | 9 | |
| Ki‐67 index, % | ||||
| ≥20 | 4 | 3 | 1 | 0.277 |
| <20 | 32 | 11 | 21 | |
| Type | ||||
| Functional | 8 | 2 | 6 | 0.441 |
| Nonfunctional | 28 | 12 | 16 | |
| Grading | ||||
| NET G1 | 21 | 8 | 13 | 0.741 |
| NET G2 | 10 | 3 | 7 | |
| NET G3 | 2 | 1 | 1 | |
| NEC | 3 | 2 | 1 | |
Abbreviations: ATX, autotaxin; NEC, neuroendocrine carcinoma; NET, neuroendocrine tumor.